Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Short-term Investments (2017 - 2025)

Organogenesis Holdings has reported Short-term Investments over the past 9 years, most recently at $2.4 million for Q4 2025.

  • Quarterly results put Short-term Investments at $2.4 million for Q4 2025, up 318.1% from a year ago — trailing twelve months through Dec 2025 was $2.4 million (up 318.1% YoY), and the annual figure for FY2025 was $2.4 million, up 318.1%.
  • Short-term Investments for Q4 2025 was $2.4 million at Organogenesis Holdings, up from $627000.0 in the prior quarter.
  • Over the last five years, Short-term Investments for ORGO hit a ceiling of $7.0 million in Q1 2025 and a floor of $487000.0 in Q3 2021.
  • Median Short-term Investments over the past 5 years was $602000.0 (2021), compared with a mean of $1.0 million.
  • Biggest five-year swings in Short-term Investments: tumbled 38.67% in 2023 and later skyrocketed 876.81% in 2025.
  • Organogenesis Holdings' Short-term Investments stood at $599000.0 in 2021, then skyrocketed by 35.56% to $812000.0 in 2022, then tumbled by 38.67% to $498000.0 in 2023, then grew by 16.47% to $580000.0 in 2024, then soared by 318.1% to $2.4 million in 2025.
  • The last three reported values for Short-term Investments were $2.4 million (Q4 2025), $627000.0 (Q3 2025), and $659000.0 (Q2 2025) per Business Quant data.